4//SEC Filing
PARMAR KUSH 4
Accession 0001664281-25-000003
CIK 0001689375other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:36 PM ET
Size
7.0 KB
Accession
0001664281-25-000003
Insider Transaction Report
Form 4
PARMAR KUSH
Director10% Owner
Transactions
- Sale
Common Stock
2025-11-14$8.80/sh−200,000$1,760,000→ 2,963,066 total(indirect: By 5AM Ventures V, L.P.)
Holdings
- 1,093,313(indirect: By 5AM Opportunities I, L.P.)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.023 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
- [F3]Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.
Documents
Issuer
Entrada Therapeutics, Inc.
CIK 0001689375
Entity typeother
Related Parties
1- filerCIK 0001664281
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:36 PM ET
- Size
- 7.0 KB